Reimagining Cesarean Healing Through Autologous Amniotic Fluid: Recibio's Perspective on the Standard of Care

image via Medical Daily

January 23, 2026, 9:27 PM

• •Recibio is advocating for the use of autologous amniotic fluid in cesarean wound closure.
• •CeaLogic products facilitate the collection and application of amniotic fluid during surgery.
• •Research shows amniotic fluid supports healing by leveraging its regenerative properties.
• •The approach aims to reduce pain, improve comfort, and foster a more natural healing process.
• •The initiative emphasizes scalability and aims for global adoption across diverse healthcare settings.

Cesarean deliveries, a common surgical procedure, are now being approached with innovative wound care solutions. Recibio, a medical technology company, is leading the way by championing the use of a mother's own amniotic fluid during cesarean wound closure to support healing and reduce complications. Research indicates that amniotic fluid, with its regenerative properties, can modulate inflammation and prevent adhesion. The company's CeaLogic product line allows for the collection and reapplication of this fluid, aiming to provide a more natural and effective healing process for mothers.

Read original article